UK King’s Daughters became the first hospital in Kentucky — and the only hospital in the region — to offer a new minimally invasive procedure for ...

South San Francisco, CA, January 30, 2025 – The California Institute for Regenerative Medicine (CIRM), one of the world’s largest institutions dedicated to regenerative medicine, has awarded nearly ...

Atalanta Therapeutics has bagged $97 million, money the biotech plans to use to launch clinical trials for its small ...

Subtle signs of neurodegeneration can be detected in blood, CSF, and neuroimaging, up to 20 years before the motor symptoms ...

Despite long COVID’s vast reach, and more than $1 billion spent on research, no new treatments have been brought to market.

Delve into the increasingly dynamic landscape of ALS treatment development with thirteen companies advancing candidates in ...

A recent study published in Cell reveals that the repeated DNA sequence that leads to Huntington’s disease (HD) expands ...

Beta blockers were associated with later appearance of motor symptoms and slower symptom worsening, but an outside expert ...

2,058 patients are benefiting from Parkinson’s medication and 149 are receiving treatment for the rare condition of ...

People genetically susceptible to Huntington's disease often see their movement, mood, and cognition decline slowly over time.

Researchers at Tufts University revealed a possible molecular mechanism explaining how the DNA repeats are broken and then expanded in the Huntington’s disease gene, pointing to a component of the ...

Yulan Xiong, associate professor of neuroscience at UConn Health, and her team have discovered one more piece of the puzzle ...